Similar articles for PMID: 20597027

Year	Number of Results
1997	1
1998	2
1999	3
2000	2
2001	2
2002	5
2003	4
2004	9
2005	10
2006	10
2007	7
2008	3
2009	6
2010	8
2011	6
2012	8
2013	4
2014	7
2015	3
2016	2
2017	1
2020	2
2021	2
2022	1
2023	1
2024	0

1

Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?

Russo RC, Garcia CC, Teixeira MM. Russo RC, et al. Curr Opin Drug Discov Devel. 2010 Jul;13(4):414-27. Curr Opin Drug Discov Devel. 2010. PMID: 20597027 Review.

2

An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.

Ali S, O'Boyle G, Mellor P, Kirby JA. Ali S, et al. Mol Immunol. 2007 Mar;44(7):1477-82. doi: 10.1016/j.molimm.2006.08.011. Epub 2006 Sep 26. Mol Immunol. 2007. PMID: 17000001 Review.

3

Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.

Donnelly LE, Barnes PJ. Donnelly LE, et al. Trends Pharmacol Sci. 2006 Oct;27(10):546-53. doi: 10.1016/j.tips.2006.08.001. Epub 2006 Aug 30. Trends Pharmacol Sci. 2006. PMID: 16911834 Review.

4

Virus-encoded chemokine receptors--putative novel antiviral drug targets.

Rosenkilde MM. Rosenkilde MM. Neuropharmacology. 2005 Jan;48(1):1-13. doi: 10.1016/j.neuropharm.2004.09.017. Neuropharmacology. 2005. PMID: 15617722 Review.

5

[Chemokines a hope of specific anti-inflammatory treatment].

Schedvins P, Hjelmström P. Schedvins P, et al. Lakartidningen. 2002 Mar 7;99(10):1056-9. Lakartidningen. 2002. PMID: 12024779 Review. Swedish.

6

The chemokine network: a target in cancer biology?

Slettenaar VI, Wilson JL. Slettenaar VI, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):962-74. doi: 10.1016/j.addr.2006.03.012. Epub 2006 Aug 15. Adv Drug Deliv Rev. 2006. PMID: 16996642 Review.

7

CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.

Yu X, Huang Y, Collin-Osdoby P, Osdoby P. Yu X, et al. J Bone Miner Res. 2004 Dec;19(12):2065-77. doi: 10.1359/JBMR.040910. Epub 2004 Sep 20. J Bone Miner Res. 2004. PMID: 15537451 Free article.

8

Anti-chemokine small molecule drugs: a promising future?

Proudfoot AE, Power CA, Schwarz MK. Proudfoot AE, et al. Expert Opin Investig Drugs. 2010 Mar;19(3):345-55. doi: 10.1517/13543780903535867. Expert Opin Investig Drugs. 2010. PMID: 20113217 Review.

9

Chemokine blockers--therapeutics in the making?

Wells TN, Power CA, Shaw JP, Proudfoot AE. Wells TN, et al. Trends Pharmacol Sci. 2006 Jan;27(1):41-7. doi: 10.1016/j.tips.2005.11.001. Epub 2005 Nov 28. Trends Pharmacol Sci. 2006. PMID: 16310864 Review.

10

Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection.

Thomas LH, Friedland JS, Sharland M. Thomas LH, et al. Expert Rev Anti Infect Ther. 2007 Jun;5(3):415-25. doi: 10.1586/14787210.5.3.415. Expert Rev Anti Infect Ther. 2007. PMID: 17547506 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year